AI GRAND ROUNDS

Authors: GEMINI(RESIDENT), GROK(ATTENDING), CHATGPT (EXPERT) & ANUPAM SINGH MD(Human in loop)

Department of Medicine, Santosh Medical College.

Click here for App | Agentic Grand Rounds Index

Round 1

User: **A 29-year-old pregnant woman (G5P3) at 26 weeks 3 days of gestation presents with a 2-week history of gradually increasing exertional dyspnea. Over the last 5 days, she has developed a nonproductive cough, nasal congestion, and subjective fevers. Most concerningly, she experienced chest tightness, palpitations, and presyncope after carrying laundry up a flight of stairs.

Her medical history is significant for Undifferentiated Connective Tissue Disease (UCTD) diagnosed 10 months prior, characterized by biopsy-proven leukocytoclastic vasculitis and intermittent cytopenias (ANA+, anti-Ro+, anti-La+, low complements). Notably, at 10 weeks of gestation, she had a syncopal episode due to severe anemia (Hb 6.2) and thrombocytopenia (Plt 40k) triggered by Parvovirus B19 infection. She is currently on Prednisone (30mg daily), Hydroxychloroquine, and Aspirin.**

Resident:

ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Attending:

ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Expert:

Hello, Expert Clinician here.

In synthesizing the clinical information provided, the most likely unifying diagnosis for this pregnant woman is a flare of her Undifferentiated Connective Tissue Disease (UCTD) with possible cardiac involvement, such as pericarditis or myocarditis, potentially exacerbated by her pregnancy. The key pivot in this case is her history of UCTD with positive anti-Ro and anti-La antibodies, which are associated with connective tissue diseases that can affect the heart, especially in the context of pregnancy.

Top Differentials:

  1. Peripartum Cardiomyopathy: This condition can present with dyspnea, palpitations, and presyncope in pregnant women, typically in the last month of pregnancy or within five months postpartum. However, it is less likely at 26 weeks of gestation and given her specific autoimmune background.

  2. Myocarditis: Given her autoimmune condition and the presence of palpitations and presyncope, myocarditis is a plausible consideration. The presence of anti-Ro and anti-La antibodies can be associated with cardiac involvement in autoimmune diseases.

  3. Pericarditis: This could explain the chest tightness and exertional symptoms, especially in the context of her connective tissue disease. However, the absence of pleuritic chest pain or a pericardial rub makes this less likely.

  4. Pulmonary Embolism: While this is a critical consideration in pregnant women with dyspnea and presyncope, the gradual onset and presence of nasal congestion and cough make it less likely.

  5. Anemia: Given her history of severe anemia, a recurrence could contribute to her symptoms, although it would not fully explain the chest tightness and palpitations.

Why Each Fits or Does Not Fit:

Most Important Next Diagnostic or Management Move:

The most important next step is to obtain an echocardiogram to evaluate cardiac function and look for evidence of myocarditis or pericarditis. This will help assess for any structural or functional cardiac abnormalities that could explain her symptoms.

Teaching Pearl:

In pregnant patients with connective tissue diseases, always consider cardiac involvement as a potential cause of new or worsening symptoms, especially when anti-Ro and anti-La antibodies are present. These antibodies are associated with neonatal lupus and can lead to cardiac complications such as congenital heart block or myocarditis in the mother.

Round 2

User: **On examination, she is febrile (38°C), tachycardic (122 bpm), tachypnea (22/min), and has an oxygen saturation of 94% on room air.

Key Physical Findings:
Neck: Elevated JVP with a prominent v wave.
Cardiac: Split S2, a holosystolic murmur at the right sternal border, and a left parasternal heave.
Lungs: Scattered crackles without wheezing.
Skin: Reticular hyperpigmentation and trace pitting edema in lower limbs.

Initial Labs:
CBC: WBC 13,700 (predominantly neutrophils), Hb 11.2, Platelets 203,000.
Respiratory Pathogen Panel: Positive for Respiratory Syncytial Virus (RSV).
Chest X-ray: Initially interpreted as "Normal."**

Resident:

ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Attending:

ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Expert:

Expert:
Hello, Expert Clinician here.

The additional clinical findings and laboratory results provide further insight into this patient's condition. The presence of a holosystolic murmur at the right sternal border, elevated JVP with a prominent v wave, and a left parasternal heave suggest significant cardiac involvement, likely related to right-sided heart strain or failure.

Unifying Diagnosis:

The most likely unifying diagnosis is acute right heart failure secondary to pulmonary hypertension, potentially exacerbated by a viral infection (RSV) and underlying connective tissue disease. The elevated JVP with a prominent v wave and the holosystolic murmur suggest tricuspid regurgitation, which can occur with right ventricular overload.

Top Differentials:

  1. Acute Right Heart Failure due to Pulmonary Hypertension: The clinical signs of elevated JVP, parasternal heave, and murmur suggest right heart strain, possibly due to pulmonary hypertension. This could be exacerbated by the RSV infection causing increased pulmonary vascular resistance.

  2. Myocarditis: The tachycardia, fever, and respiratory symptoms could be consistent with myocarditis, especially given her autoimmune background. However, the specific cardiac findings lean more towards right heart involvement.

  3. Pericarditis with Effusion: While pericarditis could explain some symptoms, the specific cardiac findings are more indicative of right heart strain rather than tamponade physiology.

  4. Pulmonary Embolism: The acute presentation with respiratory symptoms and right heart strain could suggest a pulmonary embolism, but the gradual onset and RSV positivity make this less likely.

  5. Exacerbation of UCTD with Cardiac Involvement: Her connective tissue disease could be flaring, leading to cardiac involvement, but the specific findings are more suggestive of pulmonary hypertension.

Key Pivot in the Case:

The key pivot is the combination of right heart strain signs (elevated JVP, holosystolic murmur, parasternal heave) with respiratory symptoms and RSV positivity, suggesting a pulmonary vascular issue exacerbated by infection.

Most Important Next Diagnostic or Management Move:

The most important next step is to perform an echocardiogram to assess for right ventricular function, pulmonary artery pressures, and any structural abnormalities such as tricuspid regurgitation. This will help confirm the presence of pulmonary hypertension and guide further management.

Teaching Pearl:

In patients with connective tissue diseases, viral infections can exacerbate underlying cardiac conditions, such as pulmonary hypertension, leading to acute decompensation. Always consider the impact of infections on the cardiovascular system in these patients.

Round 3

User: **An Electrocardiogram (ECG) is performed, showing sinus tachycardia with right-axis deviation and T-wave inversions in leads II, III, aVF, and V3 to V5.

A "re-read" of the initial Chest X-ray reveals:
Prominence of the right descending pulmonary artery.
A large left central pulmonary artery with obliteration of the aortopulmonary window.
Diminished retrosternal clear space on the lateral view.

Biomarkers: BNP is elevated at 362 pg/mL (Normal < 100). Troponin is normal.

Imaging:
CTPA: No pulmonary embolism. Confirms tree-in-bud nodularity (RSV) and right ventricular enlargement.
Echocardiogram: Small, hyperdynamic LV (EF 75%). Marked RV dilatation with severely reduced systolic function and septal flattening ("D-shaped" LV). Severe tricuspid regurgitation with an estimated RVSP of 74 mmHg.**

Resident:

ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Attending:

ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Expert:

Expert:
Hello, Expert Clinician here.

The additional diagnostic information solidifies the diagnosis of acute right heart failure due to severe pulmonary hypertension, likely exacerbated by the RSV infection in the context of her underlying connective tissue disease. The echocardiogram findings of marked right ventricular (RV) dilatation, severely reduced RV systolic function, and severe tricuspid regurgitation, along with an elevated right ventricular systolic pressure (RVSP), confirm significant pulmonary hypertension.

Unifying Diagnosis:

The unifying diagnosis is acute decompensated right heart failure due to severe pulmonary arterial hypertension (PAH). This is likely multifactorial, with contributions from her underlying connective tissue disease, RSV infection, and possibly pregnancy-related hemodynamic changes.

Key Findings Supporting the Diagnosis:

Most Important Next Diagnostic or Management Move:

The most important next step is to initiate treatment for pulmonary hypertension and right heart failure. This includes:

  1. Oxygen Therapy: To maintain adequate oxygenation and reduce hypoxic pulmonary vasoconstriction.
  2. Diuretics: To manage volume overload and reduce RV strain.
  3. Pulmonary Vasodilators: Consider starting medications such as phosphodiesterase-5 inhibitors (e.g., sildenafil) or endothelin receptor antagonists (e.g., bosentan) to reduce pulmonary artery pressures, in consultation with a pulmonary hypertension specialist.
  4. Close Monitoring: Given her pregnancy, close monitoring in a specialized center with expertise in managing pulmonary hypertension in pregnant patients is crucial.

Teaching Pearl:

In patients with connective tissue diseases, especially those with positive anti-Ro and anti-La antibodies, there is an increased risk of developing pulmonary arterial hypertension. This can be exacerbated by infections and pregnancy, leading to acute decompensation. Early recognition and management are critical to improving outcomes in these complex cases.

Round 4

User: **Right Heart Catheterization is performed:
Mean Pulmonary Artery Pressure (mPAP): 57 mmHg (Severe).
Pulmonary Capillary Wedge Pressure (PCWP): 5 mmHg (Normal).
Cardiac Output: 2.7 L/min (Severely low for pregnancy, where 6.0 is expected).
Pulmonary Vascular Resistance (PVR): 19.2 Wood Units (Normal < 2).
Nitric Oxide Challenge: No response (Vasoreactivity negative).

A V/Q scan is performed and is normal, ruling out Chronic Thromboembolic Pulmonary Hypertension (CTEPH).**

Resident:

ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Attending:

ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}

Expert:

Expert:
Hello, Expert Clinician here.

The right heart catheterization results confirm the diagnosis of severe pulmonary arterial hypertension (PAH). The elevated mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR), along with a normal pulmonary capillary wedge pressure (PCWP), indicate pre-capillary pulmonary hypertension, consistent with PAH rather than left heart disease. The lack of response to the nitric oxide challenge suggests that she is not a candidate for calcium channel blocker therapy, which is only effective in patients with vasoreactive PAH.

Unifying Diagnosis:

The unifying diagnosis is severe pulmonary arterial hypertension secondary to connective tissue disease, exacerbated by pregnancy and RSV infection. This condition is characterized by high pulmonary artery pressures and resistance, leading to right heart failure.

Key Findings Supporting the Diagnosis:

Most Important Next Diagnostic or Management Move:

The most important next step is to initiate targeted therapy for PAH. This includes:

  1. Pulmonary Vasodilators: Start with advanced therapies such as endothelin receptor antagonists (e.g., bosentan), phosphodiesterase-5 inhibitors (e.g., sildenafil), or prostacyclin analogs (e.g., epoprostenol or treprostinil) to lower pulmonary artery pressures and improve cardiac output.

  2. Multidisciplinary Care: Involve a team with expertise in managing PAH in pregnancy, including cardiology, pulmonology, and maternal-fetal medicine specialists.

  3. Consideration of Delivery Timing: Given the severity of her condition, discussions regarding the timing and mode of delivery should be initiated, balancing maternal and fetal risks.

Teaching Pearl:

Pulmonary arterial hypertension in the context of connective tissue diseases, especially with severe manifestations, poses significant risks during pregnancy. Early recognition and aggressive management with targeted PAH therapies are crucial to improving maternal outcomes. Multidisciplinary care is essential in managing these complex cases.

Round 1

User: **A 29-year-old pregnant woman (G5P3) at 26 weeks 3 days of gestation presents with a 2-week history of gradually increasing exertional dyspnea. Over the last 5 days, she has developed a nonproductive cough, nasal congestion, and subjective fevers. Most concerningly, she experienced chest tightness, palpitations, and presyncope after carrying laundry up a flight of stairs.

Her medical history is significant for Undifferentiated Connective Tissue Disease (UCTD) diagnosed 10 months prior, characterized by biopsy-proven leukocytoclastic vasculitis and intermittent cytopenias (ANA+, anti-Ro+, anti-La+, low complements). Notably, at 10 weeks of gestation, she had a syncopal episode due to severe anemia (Hb 6.2) and thrombocytopenia (Plt 40k) triggered by Parvovirus B19 infection. She is currently on Prednisone (30mg daily), Hydroxychloroquine, and Aspirin.**

Resident:

Hello, Chief Resident here.

This is a complex presentation of a 29-year-old pregnant patient (G5P3) at 26 weeks gestation with a background of Undifferentiated Connective Tissue Disease (UCTD) and recent Parvovirus B19 infection. The key findings are the subacute progression of exertional dyspnea and cough, culminating in an episode of chest tightness, palpitations, and presyncope—concerning for acute cardiopulmonary decompensation.

Key Findings:

  1. Cardiopulmonary Red Flags: Presyncope and chest tightness during exertion in the second trimester.
  2. UCTD Profile: ANA+, anti-Ro/SSA+, anti-La/SSB+, and low complements. This profile carries a high risk for neonatal lupus (congenital heart block) and maternal flares.
  3. Immunosuppression: Chronic prednisone (30mg) increases susceptibility to opportunistic infections and masks inflammatory markers.
  4. Hematologic Vulnerability: History of severe anemia/thrombocytopenia (Hb 6.2) triggered by Parvovirus B19, which can cause transient aplastic crisis or persistent marrow suppression in the setting of underlying autoimmune disease.
  5. Pregnancy Physiology: Increased plasma volume and cardiac output can unmask underlying cardiac or pulmonary vascular pathology.

Differential Diagnoses:

  1. Pulmonary Embolism (PE) (40%): Pregnancy is a hypercoagulable state, and systemic inflammatory diseases (UCTD) further increase VTE risk. The subacute onset of dyspnea followed by an acute exertional event (presyncope/palpitations) is highly suggestive of a PE.
  2. UCTD-associated Pulmonary Hypertension (PH) or Acute Flare (25%): Patients with Ro/La antibodies and UCTD can develop pulmonary arterial hypertension. Exertional presyncope is a classic sign of right heart strain and fixed cardiac output. Alternatively, a lupus-like serositis or pneumonitis could explain the cough and dyspnea.
  3. Anemia Recurrence/Exacerbation (20%): Given her history of Parvovirus-induced severe anemia (Hb 6.2), a recurrence of hemolysis or marrow suppression could cause high-output heart failure and exertional presyncope.
  4. Peripartum Cardiomyopathy (PPCM) or Myocarditis (10%): While PPCM usually occurs closer to delivery or postpartum, it can present in the late second trimester. UCTD also predisposes to autoimmune myocarditis.
  5. Opportunistic Infection (5%): On 30mg of Prednisone, Pneumocystis jirovecii pneumonia (PJP) or other atypical pneumonias must be considered given the nonproductive cough and dyspnea.

Recommended Prioritized Tests:

  1. Point-of-Care Ultrasound (POCUS) / Formal Echocardiogram: To assess for right ventricular strain (suggestive of PE or PH), left ventricular function (PPCM), and pericardial effusion.
  2. CT Pulmonary Angiography (CTPA) or V/Q Scan: To definitively rule out pulmonary embolism, given the high clinical suspicion and exertional syncope.
  3. Complete Blood Count (CBC) with Reticulocyte Count and Peripheral Smear: To evaluate for recurrent anemia, Parvovirus-induced aplastic crisis, or microangiopathic hemolytic anemia (MAHA).
  4. Electrocardiogram (ECG): To look for signs of right heart strain (S1Q3T3, RBBB) or arrhythmias that may explain the palpitations and presyncope.
  5. N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) and Troponin: To screen for myocardial stretch and injury.

Management Note: Given the anti-Ro/La positivity, a fetal echocardiogram is also indicated to screen for congenital heart block, though the maternal presentation is the immediate priority.

Attending:

Hello Attending Consultant here.

Critique of the proposed plan:

  1. Risk stratification is imprecise: Assigning arbitrary percentages (e.g., PE 40%) lacks evidence-based grounding; use Wells or modified Geneva criteria plus pregnancy-adjusted d-dimer before jumping to imaging probability.
  2. Missing immediate vital signs and exam correlation: No mention of oxygen saturation, heart rate, jugular venous pressure, or loud P2—critical to differentiate acute PE/PH from high-output anemia.
  3. Inadequate fetal assessment priority: At 26w3d with maternal anti-Ro/La and acute decompensation, urgent fetal echo and non-stress testing should be listed among top 3 actions, not an afterthought.
  4. Over-reliance on CTPA without risk discussion: In pregnancy, V/Q scan is often preferred first-line when chest X-ray is normal; radiation and contrast risks to fetus must be explicitly weighed.
  5. Incomplete laboratory panel: Add LDH, haptoglobin, Coombs, parvovirus IgM/PCR, and complement levels (C3/C4) to evaluate for flare, hemolysis, or persistent viral marrow suppression.
  6. Therapeutic gaps: No mention of therapeutic anticoagulation if PE is confirmed, steroid adjustment for possible flare, or empiric PJP prophylaxis given 30 mg prednisone.
  7. Echo specification: Request bubble study or agitated saline contrast to evaluate for intracardiac shunt or pulmonary hypertension; order urgent rather than “formal” to avoid delay.

These refinements sharpen diagnostic efficiency and maternal-fetal safety.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis

Pulmonary vascular/cardiac decompensation until proven otherwise — most urgently either pulmonary embolism or pulmonary hypertension/right-heart strain in a pregnant woman with connective tissue disease.

Why this is the best current frame:
- Pregnancy is strongly prothrombotic.
- UCTD/connective tissue disease raises risk for pulmonary arterial hypertension, serositis, myocarditis, and thrombosis.
- The key symptom cluster is not just URI symptoms; it is exertional chest tightness + palpitations + presyncope after stairs, on a background of progressively worsening dyspnea.
- Exertional presyncope is a major red flag for limited cardiac output/right-sided circulatory pathology such as PE, pulmonary hypertension, or cardiomyopathy/myocarditis.

Her nasal congestion/cough/subjective fever may be a concurrent viral illness, but they do not adequately explain the presyncope/chest symptoms.


Top differentials

1) Pulmonary embolism

Why it fits
- Pregnancy is a hypercoagulable state.
- Dyspnea with chest tightness and presyncope is classic concerning physiology.
- Acute worsening with exertion suggests inability to augment pulmonary blood flow.
- Autoimmune disease may further increase thrombotic risk.

Why it may not fully fit
- Symptoms evolved over 2 weeks rather than suddenly, though PE can be subacute or recurrent.
- Nonproductive cough and congestion could point to infection instead, but these are nonspecific.


2) Connective tissue disease–associated pulmonary hypertension

Why it fits
- CTD can cause pulmonary arterial hypertension, even early in disease.
- Exertional presyncope is especially suggestive.
- Pregnancy can unmask/worsen previously compensated PH because of increased plasma volume and cardiac output.
- Chest tightness, palpitations, and progressive exertional dyspnea are very compatible.

Why it may not fully fit
- We are not told of prior Raynaud, known PH, RV findings, edema, or syncope history.
- URI-like symptoms are less directly explained.

Still, this is a high-stakes diagnosis and may coexist with PE.


3) Cardiomyopathy/myocarditis (autoimmune or viral)

Why it fits
- Progressive dyspnea, palpitations, presyncope, and chest tightness.
- CTD can involve myocardium/pericardium.
- Viral prodrome symptoms raise possibility of myocarditis.
- Pregnancy increases hemodynamic stress.

Why it may not fully fit
- 26 weeks is earlier than classic peripartum cardiomyopathy, though not impossible.
- No orthopnea, edema, or clear heart failure symptoms provided.


4) Severe recurrent anemia / hemolysis / marrow suppression

Why it fits
- She previously had dramatic anemia and thrombocytopenia from parvovirus B19.
- Anemia in pregnancy can cause dyspnea, palpitations, exertional chest discomfort, and presyncope.
- Her autoimmune background also raises risk of hemolysis or cytopenic flare.

Why it may not fully fit
- Anemia alone usually does not explain the particular concern for chest tightness with exertional presyncope as well as PE/PH would.
- Cough/congestion are not directly explained.

This remains very important because severe anemia can either be the main problem or worsen any cardiopulmonary disease.


5) Infection, including viral pneumonia or opportunistic infection

Why it fits
- Subjective fever, cough, congestion.
- She is on prednisone 30 mg/day, which increases infection risk.
- PJP can present with dyspnea and nonproductive cough.

Why it may not fully fit
- Nasal congestion favors routine viral URI rather than PJP.
- Presyncope/chest tightness with stairs feels more hemodynamically significant than a simple respiratory infection.


6) Autoimmune flare with pneumonitis/serositis

Why it fits
- Low complements, cytopenic history, vasculitic disease.
- CTD flare can involve lungs, pleura, pericardium, and blood counts.

Why it may not fully fit
- The stem lacks pleuritic pain, hemoptysis, rash, or obvious inflammatory flare clues.
- Again, the hemodynamic quality of exertional presyncope pushes PE/PH/cardiac disease higher.


The key pivot in the case

The pivot is:

This is not adequately explained by “URI symptoms in pregnancy.” Exertional chest tightness with palpitations and presyncope is a cardiopulmonary warning sign that should trigger urgent evaluation for PE, pulmonary hypertension/right-heart strain, or cardiomyopathy.

That is the clinical hinge. The viral-sounding symptoms are potentially distracting.


Most important next diagnostic/management move

Immediate hospital-based evaluation with maternal stabilization and urgent cardiopulmonary assessment

Most important first steps:
1. Vitals including pulse ox
2. ECG
3. CBC, CMP, troponin, BNP/NT-proBNP
4. Chest X-ray
5. Urgent transthoracic echocardiogram
- looking for RV dilation/strain, elevated RVSP/PH, LV dysfunction, pericardial effusion
6. Definitive evaluation for PE
- If suspicion remains significant after initial assessment, proceed to pregnancy-appropriate imaging:
- V/Q scan if chest X-ray is normal
- CTPA if chest X-ray abnormal or alternative thoracic diagnosis is needed

If she is hypoxemic, tachycardic, unstable, or strongly suspected of PE, involve obstetrics + maternal-fetal medicine + cardiology/pulmonology early and consider empiric anticoagulation with LMWH while the workup proceeds, depending on bleeding risk and platelet count.


Additional high-yield tests that matter here


Why some tempting explanations are insufficient


Teaching pearl

In pregnancy, exertional presyncope is a red-flag symptom.
When dyspnea is accompanied by chest symptoms, palpitations, or presyncope, think pulmonary embolism, pulmonary hypertension, and cardiomyopathy/right-heart failure before attributing it to normal pregnancy or URI.

If you want, I can also lay this out as:
1. an ED/hospital initial order set, or
2. a ranked problem representation with illness scripts.

Round 2

User: **On examination, she is febrile (38°C), tachycardic (122 bpm), tachypnea (22/min), and has an oxygen saturation of 94% on room air.

Key Physical Findings:
Neck: Elevated JVP with a prominent v wave.
Cardiac: Split S2, a holosystolic murmur at the right sternal border, and a left parasternal heave.
Lungs: Scattered crackles without wheezing.
Skin: Reticular hyperpigmentation and trace pitting edema in lower limbs.

Initial Labs:
CBC: WBC 13,700 (predominantly neutrophils), Hb 11.2, Platelets 203,000.
Respiratory Pathogen Panel: Positive for Respiratory Syncytial Virus (RSV).
Chest X-ray: Initially interpreted as "Normal."**

Resident:

Hello, Chief Resident here.

The clinical picture has shifted dramatically with these physical findings. We are no longer looking at a simple respiratory infection; we are witnessing acute-on-chronic right heart failure.

Updated Key Findings:

  1. Right Heart Strain Signs: Elevated JVP with a prominent v wave (suggestive of tricuspid regurgitation), a left parasternal heave (RV hypertrophy/dilation), and a loud/split S2.
  2. Tricuspid Regurgitation: The holosystolic murmur at the right sternal border in this context strongly suggests functional tricuspid regurgitation due to RV dilation.
  3. Hemodynamic Instability: Tachycardia (122 bpm), tachypnea, and borderline hypoxia (94%) in a pregnant patient are highly concerning.
  4. RSV Positive: While she has a viral trigger, the physical exam findings of right heart failure are not explained by RSV alone.
  5. Stable Hematology: Hb 11.2 and Platelets 203k rule out a recurrence of her previous severe anemia/thrombocytopenia as the primary driver.

Probability-Based Diagnoses:

  1. Pulmonary Arterial Hypertension (PAH) Crisis (55%): The physical exam is classic for severe pulmonary hypertension. Patients with UCTD/Lupus-spectrum disease can have underlying PAH that decompensates in the second trimester due to the 50% increase in cardiac output. The RSV infection likely acted as the "second hit," pushing her into overt right heart failure.
  2. Acute Pulmonary Embolism (PE) (30%): Despite the "normal" CXR, the tachycardia, hypoxia, and acute right heart strain signs make PE a top priority. Pregnancy and CTD are synergistic risk factors.
  3. Acute Myocarditis / Pericarditis with Effusion (10%): Autoimmune or viral (RSV-related) myocarditis could cause acute heart failure, though the findings here are predominantly right-sided.
  4. RSV Pneumonia with Cor Pulmonale (5%): While RSV is present, the severity of the cardiac findings (heave, JVP) suggests a more chronic underlying vascular pathology or a massive acute vascular obstruction rather than just parenchymal lung disease.

Reasoning:

The presence of a left parasternal heave and prominent v waves indicates that the right ventricle is under significant pressure or volume overload. In a 26-week pregnant patient with UCTD, the most "can't miss" and likely underlying pathology is Pulmonary Hypertension, which carries a maternal mortality rate of 25-50%. The RSV infection has likely precipitated a "PAH crisis."

Recommended Prioritized Tests & Management:

  1. Urgent Transthoracic Echocardiogram (TTE): This is the most critical next step to estimate Pulmonary Artery Systolic Pressure (PASP), assess RV size/function, and look for the "D-sign" (septal flattening).
  2. NT-proBNP and Troponin: To quantify myocardial strain and injury.
  3. V/Q Scan: Given the normal CXR, a V/Q scan is the preferred next step to rule out PE while minimizing radiation compared to CTPA.
  4. Electrocardiogram (ECG): Look for S1Q3T3, right axis deviation, or RV hypertrophy patterns.
  5. Immediate ICU/MFM Consultation: This patient requires a multidisciplinary team (Cardiology, Pulmonology, Maternal-Fetal Medicine) for "PAH in pregnancy" management, which may include oxygen, cautious diuresis, and potentially advanced pulmonary vasodilators.

Warning: Avoid aggressive IV fluid boluses for her tachycardia; if this is RV failure, fluid overloading will worsen the septal shift and further decrease left ventricular cardiac output, leading to arrest.

Attending:

Hello Attending Consultant here.

Critique of the proposed plan:

  1. Probability weighting is flawed: PAH crisis at 55% is reasonable but PE at 30% underestimates its pretest likelihood given pregnancy, tachycardia, hypoxia, and acute right-heart signs; apply pregnancy-modified YEARS criteria immediately.
  2. Echo is correctly prioritized but underspecified: Request urgent TTE with agitated saline, TR velocity, RV/LV ratio, TAPSE, and estimated PASP; do not accept a delayed "formal" study.
  3. Imaging sequence is suboptimal: With normal CXR and high PE suspicion, V/Q is acceptable but CTPA may be faster and more definitive in an unstable patient; involve radiology and MFM for shared decision on contrast vs radiation risk.
  4. Missing key labs and monitoring: Add arterial blood gas, lactate, liver enzymes, BNP/NT-proBNP, troponin, D-dimer (adjusted for gestation), and repeat CBC with smear; initiate continuous fetal monitoring and telemetry now.
  5. Management gaps in RV failure: Explicitly recommend oxygen to keep SpO2 >95%, head-of-bed elevation, cautious diuresis only after echo confirmation, and avoidance of systemic vasodilators; prepare for inhaled nitric oxide or prostacyclin if severe PAH confirmed.
  6. Multidisciplinary activation is vague: Call pulmonary hypertension specialist, high-risk obstetrics, and cardiac ICU team within the hour; discuss ECMO candidacy early given 25-50% maternal mortality in PAH pregnancy.
  7. Viral trigger undervalued: RSV can cause acute cor pulmonale in vulnerable patients; add viral load quantification and consider RSV-specific supportive care while not delaying hemodynamics workup.

Refine to a single-page order set focused on stabilization, echo within 1 hour, and PE rule-out within 2 hours.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis

Previously unrecognized severe pulmonary hypertension with right ventricular failure, likely CTD-associated pulmonary arterial hypertension, now decompensated by pregnancy and RSV infection; acute PE remains the most important competing/overlapping diagnosis to urgently exclude.

This has become much more specific because the exam is now classic for chronic right-sided pressure overload with functional tricuspid regurgitation:
- Elevated JVP with prominent v wave → suggests TR/right-sided volume overload
- Left parasternal heave → RV pressure overload/enlargement
- Split/loud S2 → concerning for pulmonary hypertension
- Holosystolic murmur at right sternal border → likely tricuspid regurgitation
- Trace edema + crackles → evolving right-heart failure / mixed congestion

The normal hemoglobin removes severe anemia as the main driver.
The RSV positivity may be a trigger, but does not explain the full hemodynamic picture.


Top differentials

1) CTD-associated pulmonary arterial hypertension with RV failure

Why it fits best
- Connective tissue disease is a major cause of PAH
- Pregnancy at 26 weeks increases circulating volume and cardiac output, which can unmask/decompensate PAH
- Exam is highly supportive: parasternal heave, loud/split S2, JVP/v wave, TR murmur
- Exertional presyncope is a hallmark symptom of fixed pulmonary vascular obstruction / inability to augment output
- CXR can be “normal” early or be misread

Why caution remains
- Need echo confirmation and definition of severity
- Must still exclude PE because it can mimic or coexist


2) Pulmonary embolism causing acute right-heart strain

Why it still strongly fits
- Pregnancy = high VTE risk
- Acute worsening, tachycardia, borderline hypoxemia, chest tightness, presyncope
- Can produce RV strain, TR, elevated JVP
- Chest X-ray being “normal” does not lower PE concern much

Why it is slightly less unifying than PAH
- The exam suggests more than purely acute disease; parasternal heave and clear TR physiology raise concern for pre-existing pulmonary vascular disease
- Still, acute PE superimposed on chronic PAH is very plausible and dangerous


3) RV-predominant cardiomyopathy/myocarditis

Why it fits
- Viral symptoms + RSV
- Tachycardia, dyspnea, crackles, presyncope
- Can present with arrhythmia and heart failure

Why it fits less well
- The exam pattern is more pulmonary vascular/right-sided pressure overload than primary LV failure
- Myocarditis usually gives a less specific right-heart exam unless secondary pulmonary hypertension develops


4) RSV lower respiratory tract infection/pneumonia causing cardiopulmonary stress

Why it fits partly
- Fever, neutrophilic leukocytosis, cough, RSV+
- Infection can precipitate decompensation of underlying cardiopulmonary disease

Why it does not fully fit
- RSV alone does not explain prominent v waves, parasternal heave, split S2, exertional presyncope
- “Scattered crackles” without significant infiltrates or wheeze is not enough


5) Autoimmune flare with pulmonary or cardiac involvement

Why it fits
- UCTD with hypocomplementemia and prior cytopenias
- CTD can cause pneumonitis, serositis, myocarditis, or worsen pulmonary vascular disease

Why it is not the leading immediate diagnosis
- Current bedside physiology points more specifically toward pulmonary vascular/RV pathology
- The urgent task is defining the hemodynamic lesion


Why the RSV result and initially “normal” CXR are a trap

The key danger here is anchoring on RSV and missing a lethal maternal diagnosis.

In other words, the physical exam has now outranked the chest X-ray.


The key pivot in the case

The exam converts this from nonspecific dyspnea in pregnancy into a syndrome of right-heart failure/right-heart strain.

That is the pivot.

The combination of:
- JVP elevation with v waves
- left parasternal heave
- split S2
- TR-type murmur
- exertional presyncope

is the bedside signature of pulmonary hypertension/RV failure until proven otherwise.


Most important next diagnostic move

Urgent transthoracic echocardiogram right now

This is the single most important next test because it will rapidly determine whether she has:
- severe RV dilation/dysfunction
- elevated estimated pulmonary pressures
- significant tricuspid regurgitation
- septal flattening/D-sign
- LV dysfunction/myocarditis pattern
- pericardial effusion

This will also help risk-stratify whether she is in impending RV collapse.

In parallel: urgent evaluation for PE

Because PE remains a cannot-miss diagnosis, she also needs definitive pulmonary vascular imaging promptly:
- V/Q scan is reasonable if CXR truly normal and she is stable enough
- CTPA if faster, if CXR not truly normal, or if alternate thoracic pathology needs evaluation

In a deteriorating patient, speed and diagnostic certainty matter more than theoretical sequencing.


Most important immediate management move

Admit to a monitored setting/ICU-level maternal care and treat as decompensated RV failure

Immediate actions:
- Oxygen to maintain maternal saturation ideally >95%
- Continuous telemetry
- Maternal-fetal medicine + cardiology + pulmonary hypertension/ICU team
- Avoid large IV fluid boluses
- RV failure worsens with overfilling
- Consider careful diuresis only if congestion is evident and blood pressure tolerates it, ideally after echo guidance
- If PE suspicion remains high and bleeding risk acceptable, consider therapeutic anticoagulation while definitive imaging is pursued
- Avoid anything that increases pulmonary vascular resistance:
- hypoxemia
- acidosis
- pain/agitation
- excessive positive pressure if possible

If severe PAH/RV failure is confirmed, this may require specialized pulmonary vasodilator support.


Key additional tests now


Best concise synthesis

This pregnant patient with UCTD has bedside findings most consistent with significant pulmonary hypertension and right-sided heart failure, likely pre-existing CTD-associated PAH now decompensated by pregnancy and RSV, with superimposed pulmonary embolism still needing urgent exclusion.


Teaching pearl

In dyspneic pregnancy, a “viral diagnosis” should never end the evaluation when the exam shows right-heart strain.
A parasternal heave + loud/split S2 + JVP elevation with TR murmur + exertional presyncope is a high-yield bedside pattern for pulmonary hypertension/RV failure.

If you want, I can next provide:
1. a prioritized ICU/ED order set, or
2. a maternal mortality–focused management plan for pulmonary hypertension in pregnancy.

Round 3

User: **An Electrocardiogram (ECG) is performed, showing sinus tachycardia with right-axis deviation and T-wave inversions in leads II, III, aVF, and V3 to V5.

A "re-read" of the initial Chest X-ray reveals:
Prominence of the right descending pulmonary artery.
A large left central pulmonary artery with obliteration of the aortopulmonary window.
Diminished retrosternal clear space on the lateral view.

Biomarkers: BNP is elevated at 362 pg/mL (Normal < 100). Troponin is normal.

Imaging:
CTPA: No pulmonary embolism. Confirms tree-in-bud nodularity (RSV) and right ventricular enlargement.
Echocardiogram: Small, hyperdynamic LV (EF 75%). Marked RV dilatation with severely reduced systolic function and septal flattening ("D-shaped" LV). Severe tricuspid regurgitation with an estimated RVSP of 74 mmHg.**

Resident:

Resident:
Hello, Chief Resident here.

The diagnosis is now definitive: Severe Pulmonary Arterial Hypertension (PAH) with Acute Right Ventricular (RV) Failure, likely chronic CTD-associated PAH that has reached a tipping point due to the hemodynamic demands of the second trimester and an acute RSV infection.

Updated Key Findings:

  1. Hemodynamic Signature: RVSP of 74 mmHg (severe PH) with "D-shaped" LV (pressure/volume overload causing septal shift).
  2. RV Failure: Severely reduced RV systolic function and elevated BNP (362 pg/mL) indicate the RV is no longer compensating.
  3. ECG Findings: Right axis deviation and T-wave inversions in precordial/inferior leads are classic for RV strain.
  4. Radiographic Clues: The "normal" CXR actually showed enlarged central pulmonary arteries and RV enlargement (diminished retrosternal space), which were initially overlooked.
  5. PE Excluded: CTPA has ruled out acute pulmonary embolism, focusing our management entirely on PAH and RSV.

Probability-Based Diagnoses:

  1. CTD-associated Pulmonary Arterial Hypertension (PAH) (90%): Given her UCTD (anti-Ro/La+), this is the most likely etiology. The second trimester (26 weeks) is the classic window for decompensation as cardiac output peaks.
  2. RSV-induced Cor Pulmonale (10%): While RSV is present (tree-in-bud on CT), it is the precipitant rather than the primary cause of an RVSP of 74 mmHg.

Reasoning:

The patient is in a Pulmonary Hypertension Crisis. The "D-shaped" LV is a critical finding; it explains her exertional presyncope. When she exerts herself, RV pressure rises further, pushing the septum into the LV, which reduces LV filling (preload) and leads to a sudden drop in systemic cardiac output. This is a life-threatening emergency in pregnancy, with maternal mortality historically cited between 25% and 50%.

Recommended Prioritized Management (ICU/MFM):

  1. Preload Optimization: Avoid aggressive fluid boluses. While she is tachycardic, more fluid will worsen the septal shift and LV compression. Cautious diuresis (e.g., low-dose Furosemide) may be needed if there is systemic congestion, but must be done with extreme care to avoid dropping RV preload too far.
  2. Afterload Reduction (Pulmonary Vasodilators): Initiate Inhaled Nitric Oxide (iNO) or Inhaled Prostacyclins (e.g., Epoprostenol). These are preferred in the acute setting because they are selective for the pulmonary vasculature and have minimal systemic hypotensive effects.
  3. Maintain Systemic Blood Pressure: If she becomes hypotensive, use Norepinephrine or Vasopressin to maintain systemic vascular resistance (SVR). SVR must remain higher than Pulmonary Vascular Resistance (PVR) to prevent worsening of the right-to-left septal shift.
  4. Oxygenation: Maintain SpO2 > 95%. Hypoxia is a potent pulmonary vasoconstrictor and will worsen the PH.
  5. Multidisciplinary Delivery Planning: At 26 weeks, the fetus is viable but extremely premature. The goal is maternal stabilization. Delivery is the only "cure" for the pregnancy-induced hemodynamic stress, but the act of delivery (especially the Valsalva maneuver or sudden fluid shifts postpartum) is the highest-risk period for maternal death.
  6. Fetal Surveillance: Continuous fetal monitoring is required, as maternal RV failure directly impairs placental perfusion.

Next Steps:

Transfer to a specialized Pulmonary Hypertension center if not already there. Discuss the transition to long-term PAH therapies (e.g., Sildenafil, which is generally considered safe in pregnancy) once stabilized. The RSV should be treated supportively. Strict avoidance of future pregnancies must be discussed once the crisis is resolved, given the extreme risk.

Attending:

Hello Attending Consultant here.

Critique of the proposed plan:

  1. Diagnostic synthesis is accurate but incomplete: Confirm Group 1 PAH (CTD-associated) with acute decompensation; explicitly note that tree-in-bud is incidental and that normal troponin with elevated BNP localizes injury to RV strain rather than ischemia.
  2. Preload management is imprecise: Specify echo-guided volume assessment (IVC collapsibility, hepatic vein flow) before any diuresis; avoid empiric furosemide at this stage as RV is preload-dependent in severe PH.
  3. Pulmonary vasodilator choice is suboptimal: Prioritize inhaled epoprostenol or nitric oxide over sildenafil initiation in acute crisis; sildenafil may cause systemic vasodilation and worsen septal shift if SVR falls.
  4. Hemodynamic support gaps: Recommend invasive monitoring (arterial line, central venous pressure) and norepinephrine as first-line vasopressor to preserve coronary perfusion pressure; avoid vasopressin as primary agent due to potential PVR increase.
  5. Delivery planning premature: At 26w3d with unstable RV, defer any delivery discussion until maternal stabilization (target RVSP reduction, improved septal geometry); involve MFM for serial fetal echo to monitor for anti-Ro/La-mediated heart block.
  6. Supportive care omissions: Add RSV-specific antiviral consideration if progressing to severe pneumonia, therapeutic anticoagulation hold given no PE, and serial lactate/ScvO2 to gauge tissue perfusion.
  7. Long-term counseling misplaced: Postpone sterilization discussion until postpartum stabilization; focus now on ECMO candidacy and transfer to tertiary PH-pregnancy center.

Refine to immediate stabilization bundle: echo-directed therapy, selective pulmonary vasodilation, and multidisciplinary huddle within 1 hour.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis

Severe pulmonary arterial hypertension with decompensated right ventricular failure, most likely connective tissue disease–associated PAH, unmasked/worsened by pregnancy and precipitated by RSV respiratory infection.

This is now the clear diagnosis.

Why this is the best fit

The data are internally coherent for advanced pulmonary vascular disease with RV failure:
- ECG: right-axis deviation + anterior/inferior T-wave inversions = RV strain
- CXR re-read: enlarged central pulmonary arteries + reduced retrosternal clear space = pulmonary artery enlargement + RV enlargement
- CTPA: no PE, but RV enlargement
- Echo:
- marked RV dilation
- severely reduced RV systolic function
- septal flattening/D-shaped LV = RV pressure overload
- severe tricuspid regurgitation
- RVSP ~74 mmHg = severe pulmonary hypertension
- small hyperdynamic LV = underfilled LV from interventricular septal shift / impaired preload
- BNP elevated, troponin normal = myocardial wall stress, especially RV strain, without clear ischemic injury

This explains:
- progressive exertional dyspnea
- palpitations
- exertional presyncope
- elevated JVP/v wave
- parasternal heave
- split S2
- TR murmur
- edema/crackles


Most likely etiology

CTD-associated PAH

Her UCTD background makes this the leading cause:
- autoimmune connective tissue disease is a classic substrate for Group 1 PAH
- pregnancy increases blood volume and cardiac output, often exposing previously compensated pulmonary vascular disease
- RSV likely precipitated decompensation, rather than caused the underlying hemodynamic disease


Top differentials now

1) CTD-associated PAH with acute RV failure — best diagnosis

Fits because
- classic exam, ECG, CXR, echo, BNP pattern
- autoimmune disease is a strong etiologic clue
- PE has been excluded on CTPA

Does not fit less well than alternatives
- It explains both the chronicity and the acute tipping point


2) Pulmonary hypertension from other causes, not purely Group 1

Still worth considering as part of the etiologic workup, though not the immediate management pivot.

Possibilities:
- chronic thromboembolic disease
- interstitial lung disease/hypoxic lung disease
- left-sided cardiac disease less likely here
- portal hypertension/congenital disease depending on history

Why less likely right now
- Current data strongly favor precapillary pulmonary vascular disease with RV failure
- CTPA excluded acute PE, but not all chronic thromboembolic disease


3) Myocarditis/cardiomyopathy

Why it was plausible
- viral trigger, pregnancy, dyspnea, palpitations

Why it is now less likely
- LV is hyperdynamic and small, not failing
- echo phenotype is RV pressure overload, not primary global cardiomyopathy
- troponin is normal


4) RSV pneumonia/cor pulmonale

Why it contributes
- RSV likely increased hypoxic pulmonary vasoconstriction and cardiopulmonary stress
- CT shows tree-in-bud nodularity consistent with viral bronchiolar process

Why it is not the primary diagnosis
- RSV does not explain severe pulmonary artery enlargement and this degree of RV remodeling/decompensation by itself
- It is best viewed as a trigger


The key pivot in the case

The key pivot is the echo: small hyperdynamic LV + massively abnormal RV + D-shaped septum + severe TR + RVSP 74.

That pattern is the bedside-and-imaging signature of severe precapillary pulmonary hypertension with RV failure, not PE, not anemia, and not primary LV disease.


Most important next management move

Immediate ICU-level stabilization at a pulmonary hypertension-capable center with urgent initiation of RV-failure–focused therapy

This is the most important move.

Core management principles

  1. Oxygen
    - keep saturation high, ideally >95% in pregnancy
    - avoid hypoxemia because it worsens pulmonary vasoconstriction

  2. Avoid RV precipitants
    - no large fluid boluses
    - avoid hypovolemia too
    - avoid acidosis, pain, agitation, hypothermia
    - avoid unnecessary positive-pressure ventilation if possible, as it can worsen RV preload and afterload dynamics

  3. Selective pulmonary vasodilation
    - in acute decompensation, consider inhaled nitric oxide or inhaled epoprostenol/prostacyclin
    - these can reduce pulmonary vascular resistance while minimizing systemic hypotension

  4. Hemodynamic support if needed
    - if hypotensive or showing low output, norepinephrine is generally preferred to maintain coronary perfusion and systemic pressure
    - arterial line is appropriate in a deteriorating patient

  5. Careful preload management
    - if clinically congested, cautious diuresis may help
    - but this should be done carefully because severe RV failure is preload sensitive

  6. Multidisciplinary team now
    - maternal-fetal medicine
    - pulmonary hypertension specialist
    - cardiac ICU/critical care
    - anesthesia
    - cardiology
    - neonatology if maternal deterioration threatens delivery timing


What should happen diagnostically after stabilization

Although the syndrome is now clear, formal etiologic classification still matters.

Next diagnostic step after immediate stabilization

Right heart catheterization at an expert center, if the team believes it can be done safely and will alter management.

Why:
- confirms precapillary PH physiology
- measures RA pressure, PAP, PCWP, cardiac output, PVR
- guides vasodilator and inotrope strategy
- helps distinguish severity and prognosis

In a crashing patient, therapy may begin before definitive catheter-based characterization.

Additional etiologic workup

Once stabilized:
- autoimmune assessment/activity
- V/Q scan later if concern for chronic thromboembolic PH persists despite negative CTPA
- pulmonary function testing and diffusion capacity
- evaluation for ILD, sleep-disordered breathing, liver disease, congenital shunt if relevant


Important management nuance in pregnancy

Pregnancy with severe PAH carries very high maternal risk, especially:
- late pregnancy
- labor/delivery
- early postpartum fluid shifts

So the immediate priority is maternal stabilization, not reflex delivery. Delivery can be catastrophic if undertaken before hemodynamics are optimized.


Why anticoagulation is not the main move now


One teaching pearl

A small hyperdynamic LV in a dyspneic patient can be a clue to severe RV failure, not circulatory wellness.
When the RV is pressure overloaded, the septum bows into the LV, reducing LV filling; the LV may look “strong” but is actually underfilled, and the patient is at risk for low-output collapse.

If you want, I can next provide a stepwise ICU management algorithm for decompensated PAH in pregnancy.

Round 4

User: **Right Heart Catheterization is performed:
Mean Pulmonary Artery Pressure (mPAP): 57 mmHg (Severe).
Pulmonary Capillary Wedge Pressure (PCWP): 5 mmHg (Normal).
Cardiac Output: 2.7 L/min (Severely low for pregnancy, where 6.0 is expected).
Pulmonary Vascular Resistance (PVR): 19.2 Wood Units (Normal < 2).
Nitric Oxide Challenge: No response (Vasoreactivity negative).

A V/Q scan is performed and is normal, ruling out Chronic Thromboembolic Pulmonary Hypertension (CTEPH).**

Resident:

Resident:
Hello, Chief Resident here.

The Right Heart Catheterization (RHC) and V/Q scan have provided the definitive hemodynamic and etiologic classification. We are dealing with Group 1 Pulmonary Arterial Hypertension (PAH), specifically associated with Undifferentiated Connective Tissue Disease (UCTD), in a state of acute-on-chronic right ventricular failure.

Updated Key Findings:

  1. Hemodynamic Profile: mPAP of 57 mmHg with a normal PCWP (5 mmHg) confirms pre-capillary pulmonary hypertension.
  2. Severe Vascular Resistance: PVR of 19.2 Wood Units is extremely high (nearly 10 times the upper limit of normal). This indicates profound remodeling of the pulmonary vasculature.
  3. Low Output State: A cardiac output of 2.7 L/min is critically low, especially in the second trimester when physiologic demands require ~6.0 L/min. This explains her exertional presyncope and tachycardia.
  4. Vasoreactivity Negative: No response to Nitric Oxide indicates that the pulmonary vascular obstruction is fixed/remodeled rather than purely vasospastic, necessitating advanced PAH-specific therapies (prostacyclins) rather than calcium channel blockers.
  5. CTEPH Ruled Out: The normal V/Q scan definitively excludes chronic thromboembolic disease, pointing squarely to CTD-associated small-vessel disease.

Probability-Based Diagnoses:

  1. CTD-associated Pulmonary Arterial Hypertension (Group 1 PAH) (100%): The RHC findings are pathognomonic for pre-capillary PAH in the setting of her known UCTD. The RSV infection was the physiological "tipping point" for her already compromised RV.

Reasoning:

The patient is in a low-output state due to RV-LV mismatch. The high PVR prevents the RV from pumping blood through the lungs to the left heart. The resulting low LV preload (demonstrated by the "small, hyperdynamic LV" on echo and low CO on RHC) leads to systemic hypotension and syncope during exertion. At 26 weeks, she is in the most dangerous period of pregnancy for this condition.

Recommended Prioritized Management & Next Steps:

  1. Initiate Parenteral Prostacyclins: Given the severity (PVR > 19, low CO, and non-reactive RHC), she requires continuous intravenous or subcutaneous prostacyclin analogues (e.g., Epoprostenol or Treprostinil). This is the gold standard for high-risk Group 1 PAH.
  2. Inotropic Support: Consider Milrinone or Dobutamine to improve RV contractility and reduce PVR (Milrinone has the benefit of being a pulmonary vasodilator, though systemic hypotension must be monitored).
  3. Strict Fluid Balance: Use invasive monitoring (CVP/Arterial line) to maintain the "sweet spot" of RV preload. She likely needs cautious diuresis to reduce RV wall stress, but must maintain enough volume to fill the LV.
  4. Multidisciplinary Delivery Planning: Delivery is the only way to remove the 50% increase in cardiac output demand. However, the peripartum period is the highest risk for maternal death (due to sudden shifts in preload and SVR).
    • The goal is to stabilize her hemodynamics with prostacyclins for several days/weeks before considering a planned, highly controlled delivery (usually via C-section with specialized anesthesia).
  5. Fetal Protection: Given her anti-Ro/La status and maternal low-output state, the fetus is at high risk for both congenital heart block and growth restriction/distress. Daily fetal surveillance is mandatory.

Final Clinical Synthesis:

This is a classic but tragic presentation of CTD-associated PAH unmasked by pregnancy. The patient’s UCTD (likely a precursor to Systemic Sclerosis or SLE) caused silent pulmonary vascular remodeling that became symptomatic only when pregnancy and RSV increased the hemodynamic burden beyond the RV's compensatory capacity. The focus is now on aggressive pulmonary vasodilation and preventing maternal cardiovascular collapse during the upcoming delivery.

Attending:

Hello Attending Consultant here.

Critique of the proposed plan:

  1. Hemodynamic interpretation incomplete: Low CO (2.7 L/min) with mPAP 57 mmHg, PCWP 5 mmHg, and PVR 19.2 WU confirms high-risk Group 1 CTD-PAH (WHO FC IV equivalent); explicitly calculate cardiac index and note negative vasoreactivity precludes any CCB trial.
  2. Therapy sequencing suboptimal: Parenteral prostacyclin (IV epoprostenol preferred over SC treprostinil in acute crisis) must be titrated first-line before adding inotropes; milrinone risks systemic vasodilation and further septal shift in this non-reactive, low-SVR-potential state.
  3. Preload management vague: Target CVP 8-12 mmHg or use echo-derived RV stroke volume optimization; empiric diuresis is hazardous with CO already critically low—prioritize volume assessment via continuous ScvO2 or lactate clearance.
  4. Inotrope choice imprecise: Dobutamine or low-dose epinephrine better than milrinone initially to support RV contractility without excessive pulmonary vasodilation mismatch; add norepinephrine if MAP <65 mmHg to preserve RV coronary perfusion.
  5. Delivery timing premature and risky: At 26w3d with CO 2.7 L/min, defer any delivery planning until 48-72 h of prostacyclin stabilization and RVSP reduction; immediate delivery risks peripartum collapse from autotransfusion and PVR surge.
  6. Fetal monitoring gap: Daily fetal echo for anti-Ro/La heart block is mandatory but secondary to maternal arterial line, PA catheter (if retained), and goal-directed therapy targeting CI >3.0 L/min/m².
  7. Multidisciplinary and center-of-excellence omission: Immediate transfer to a PH-pregnancy referral center with ECMO capability is essential given 30-50% maternal mortality; RSV supportive care and serial biomarkers (BNP, lactate) must integrate into the bundle.

Refine to a 24-hour stabilization protocol focused on prostacyclin up-titration, invasive hemodynamics, and MFM/PH team huddle before any obstetric intervention.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis

High-risk Group 1 pulmonary arterial hypertension, most likely connective tissue disease–associated PAH, with severe decompensated right ventricular failure in pregnancy.

The hemodynamics are definitive:
- mPAP 57 mmHg → severe pulmonary hypertension
- PCWP 5 mmHg → precapillary process, not left-sided heart failure
- PVR 19.2 WU → profound pulmonary vascular disease
- CO 2.7 L/min → critically low output, especially abnormal in pregnancy
- No vasoreactivity to nitric oxide → not a calcium-channel-blocker candidate
- Normal V/Q scan → argues strongly against CTEPH

So this is no longer just “pulmonary hypertension”; it is severe precapillary PAH with low-output RV failure, and the most plausible etiology is her underlying connective tissue disease.


Why this fits best

This integrates the whole case:
- Subacute exertional dyspnea progressing to exertional presyncope
- Exam showing TR, RV heave, elevated JVP, loud/split S2
- ECG with RV strain
- Imaging showing RV enlargement and enlarged pulmonary arteries
- Echo showing severe RV dysfunction with septal flattening
- RHC confirming severe precapillary pulmonary vascular disease
- Pregnancy and RSV acting as decompensating stressors

This is classic physiology of:

fixed severe pulmonary vascular resistance → RV failure → underfilled LV → low cardiac output → presyncope/exertional collapse risk


Top differentials and why they now fall away

1) CTD-associated Group 1 PAH — overwhelmingly favored

Fits
- Established autoimmune disease
- Clear precapillary PH on catheterization
- CTEPH excluded
- No evidence of left heart disease
- Hemodynamics severe and characteristic

Doesn’t not fit
- This is the diagnosis unless a rare alternative CTD-adjacent cause emerges


2) Pulmonary hypertension related to parenchymal lung disease/infection

Why it was considered
- RSV positive
- Tree-in-bud nodularity

Why it does not explain the syndrome
- RSV/bronchiolitis does not usually produce PVR 19.2 WU with this degree of chronic RV remodeling
- Infection is a trigger, not the primary disease


3) CTEPH

Why it mattered
- Can present with severe precapillary PH and RV failure

Why it is now effectively excluded
- Normal V/Q scan
- No acute PE on CTPA


4) Left-sided cardiac disease/myocardiopathy

Why it was in the early differential
- Dyspnea, crackles, BNP elevation

Why it is not the answer
- PCWP normal
- LV is small and hyperdynamic, not failing
- Hemodynamics are precapillary, not postcapillary


The key pivot in the case

The decisive pivot is the right heart catheterization: severe precapillary pulmonary hypertension with markedly elevated PVR and very low cardiac output.

That moves the case from suspected PH to a hemodynamically proven, high-risk PAH crisis phenotype.


Most important next management move

Immediate initiation/up-titration of parenteral prostacyclin therapy in a pulmonary hypertension–expert ICU, with invasive hemodynamic support and maternal stabilization as the absolute priority.

This is the most important move.

Why

She is high risk by every major feature:
- severe symptoms
- RV failure
- elevated BNP
- low cardiac output
- severe PVR elevation
- pregnancy

For this phenotype, parenteral prostacyclin, especially IV epoprostenol, is the cornerstone therapy.


Best immediate management priorities

1) Start IV epoprostenol

Why:
- strongest evidence and most established rescue/bridge therapy in severe PAH
- appropriate for high-risk, low-output, RV failure disease
- nonreactive vasodilator testing means do not use calcium channel blockers

Can also consider adjuncts later:
- PDE-5 inhibitor such as sildenafil
- inhaled pulmonary vasodilators in the acute phase
But the anchor therapy is parenteral prostacyclin.


2) ICU-level RV failure management

Goals:
- maintain systemic pressure to preserve RV coronary perfusion
- avoid precipitants of rising PVR:
- hypoxemia
- acidosis
- pain/anxiety
- hypercapnia
- excessive PEEP if intubated


3) Careful hemodynamic support

This is a narrow hemodynamic window:
- too much volume worsens RV dilation and septal shift
- too little volume drops LV filling further


4) Maternal stabilization before obstetric intervention

This is crucial.

At 26 weeks, immediate delivery is not the reflex move unless there is refractory maternal collapse or an obstetric indication that cannot wait.
The highest-risk period for PAH patients is often delivery and early postpartum, because of sudden preload/autotransfusion shifts.

So:
- stabilize first
- coordinated planning by MFM + PH team + cardiac anesthesia + ICU + neonatology
- delivery only in a controlled, expert setting once a strategy exists


Important things not to do


Additional useful classification point

This is essentially:
- WHO Group 1 PAH
- likely CTD-associated
- with high-risk features / near WHO functional class IV physiology

Her cardiac output is especially ominous in pregnancy because normal gestation should increase output substantially; instead she is profoundly low output.


Prognostic significance

This is a maternal high-mortality condition, especially:
- second/third trimester
- delivery
- postpartum

The low CO and severe RV dysfunction are the most worrisome prognostic elements.


Teaching pearl

In pulmonary hypertension, the most dangerous number is often not the pulmonary pressure alone—it is the cardiac output.
A patient with very high PAP but preserved RV output may compensate; once the RV fails and cardiac output falls, risk of syncope, shock, and death rises sharply.

If you want, I can next give:
1. a 24-hour ICU stabilization protocol, or
2. a board-style final diagnosis + management summary.

Top 15 Takeaways for Clinicians

  1. Exertional presyncope in pregnancy is a cardiopulmonary emergency, never "just pregnancy." Think PE, pulmonary hypertension, or cardiomyopathy before attributing it to normal gestation.
  2. A normal chest X-ray does not exclude pulmonary hypertension, PE, or RV failure. Ask radiology to specifically re-review for PAH stigmata.
  3. The bedside triad of parasternal heave + loud/split S2 + elevated JVP with v waves signals RV pressure overload. This physical exam constellation should immediately narrow the differential to pulmonary hypertension.
  4. A positive respiratory viral panel can be a dangerous distractor. RSV positivity explained congestion but anchoring on a viral diagnosis almost delayed recognition of life-threatening PAH.
  5. CTD, especially with anti-Ro/La antibodies, is a major risk factor for Group 1 PAH. UCTD, SLE, and SSc can cause silent pulmonary vascular remodeling that decompensates during pregnancy.
  6. A "small, hyperdynamic LV" often means the LV is underfilled from RV failure. Septal flattening into the LV (D-shaped septum) is the hallmark of RV pressure overload.
  7. An estimated RVSP of 74 mmHg with severe TR and RV dilatation constitutes a PH crisis in pregnancy. Maternal mortality for severe PAH in pregnancy is 25–50%; immediate ICU-level care is mandatory.
  8. Right heart catheterization is essential for classifying PH as pre-capillary versus post-capillary. A normal PCWP with elevated mPAP and PVR confirms Group 1 PAH.
  9. The most dangerous number in PAH is not the PAP—it is the cardiac output. A CO of 2.7 L/min when pregnancy demands ~6.0 L/min indicates critically low output.
  10. Never give large IV fluid boluses to a patient in RV failure. Volume loading worsens RV dilation and can precipitate cardiac arrest.
  11. Negative vasoreactivity testing means CCBs are contraindicated. These patients require parenteral prostacyclin therapy as first-line.
  12. Delivery is not the first move in PAH crisis—maternal stabilization must precede obstetric intervention. The peripartum period is the highest-risk window for maternal death.
  13. Normal troponin with elevated BNP localizes injury to myocardial wall stress rather than ischemia. This pattern helps distinguish decompensated PAH from ACS or myocarditis.
  14. A normal V/Q scan after negative CTPA is required to definitively exclude CTEPH. CTEPH is a surgically curable cause of PH.
  15. An arterial line, continuous telemetry, and avoidance of hypoxemia, acidosis, pain, and hypercapnia are the immediate RV-protective bundle. Each factor increases PVR and can precipitously worsen RV failure.